APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inosine Pranobex

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Selected research

Industry Growth & Trends

Global Inosine Pranobex Industry Growth and Trends Forecast to 2032

26 December 2025104 pages

Choose your research edition.

Industry ResearchInosine Pranobex Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Inosine Pranobex Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Inosine Pranobex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inosine Pranobex Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inosine Pranobex Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.

Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.

Read the full market overview

In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.

Report Scope

This report provides a structured, data-driven view of the global Inosine Pranobex market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inosine Pranobex market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inosine Pranobex market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inosine Pranobex.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inosine Pranobex market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inosine Pranobex Market by Company

Newport Pharmaceuticals

Gedeon Richter

Mochida

Sanofi

Andrómaco

Yung Shin

Alfasigma S.p.A.

Polfarmex

Sanfer

Meprofarm

Novell Pharmaceutical

Aflofarm

Inosine Pranobex Segment by Type

Tablet

Syrup

Inosine Pranobex Segment by Application

Immunomodulation

Antiviral

Other

Inosine Pranobex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inosine Pranobex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inosine Pranobex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inosine Pranobex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inosine Pranobex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Syrup Table 3. Global Inosine Pranobex Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 5. Global Inosine Pranobex Sales Market Share in Volume by Type (2021-2026) Table 6. Global Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 7. Global Inosine Pranobex Sales Market Share in Value by Type (2021-2026) Table 8. Global Inosine Pranobex Price by Type (2021-2026) & (USD/Unit) Table 9. Global Inosine Pranobex Sales by Type (2027-2032) & (K Units) Table 10. Global Inosine Pranobex Sales Market Share in Volume by Type (2027-2032) Table 11. Global Inosine Pranobex Sales by Type (2027-2032) & (US$ Million) Table 12. Global Inosine Pranobex Sales Market Share in Value by Type (2027-2032) Table 13. Global Inosine Pranobex Price by Type (2027-2032) & (USD/Unit) Table 14. North America Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 15. North America Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 17. Europe Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 21. Latin America Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Inosine Pranobex Sales by Type (2021-2026) & (US$ Million) Table 24. Inosine Pranobex Industry Trends Table 25. Inosine Pranobex Industry Drivers Table 26. Inosine Pranobex Industry Opportunities and Challenges Table 27. Inosine Pranobex Industry Restraints Table 28. Global Inosine Pranobex Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Inosine Pranobex Revenue Market Share by Company (2021-2026) Table 30. Global Inosine Pranobex Sales by Company (2021-2026) & (K Units) Table 31. Global Inosine Pranobex Sales Share by Company (2021-2026) Table 32. Global Inosine Pranobex Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Inosine Pranobex Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Inosine Pranobex Major Company Production Sites and Headquarters Table 35. Global Inosine Pranobex Company, Product Type & Application Table 36. Global Inosine Pranobex Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Inosine Pranobex by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Inosine Pranobex Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Inosine Pranobex Sales by Region (2021-2026) & (K Units) Table 41. Global Inosine Pranobex Sales Market Share in Volume by Region (2021-2026) Table 42. Global Inosine Pranobex Sales by Region (2021-2026) & (US$ Million) Table 43. Global Inosine Pranobex Sales Market Share in Value by Region (2021-2026) Table 44. Global Inosine Pranobex Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Inosine Pranobex Sales by Region (2027-2032) & (K Units) Table 46. Global Inosine Pranobex Sales Market Share in Volume by Region (2027-2032) Table 47. Global Inosine Pranobex Sales by Region (2027-2032) & (US$ Million) Table 48. Global Inosine Pranobex Sales Market Share in Value by Region (2027-2032) Table 49. Global Inosine Pranobex Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Inosine Pranobex Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 52. Global Inosine Pranobex Sales Market Share in Volume by Application (2021-2026) Table 53. Global Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 54. Global Inosine Pranobex Sales Market Share in Value by Application (2021-2026) Table 55. Global Inosine Pranobex Price by Application (2021-2026) & (USD/Unit) Table 56. Global Inosine Pranobex Sales by Application (2027-2032) & (K Units) Table 57. Global Inosine Pranobex Sales Market Share in Volume by Application (2027-2032) Table 58. Global Inosine Pranobex Sales by Application (2027-2032) & (US$ Million) Table 59. Global Inosine Pranobex Sales Market Share in Value by Application (2027-2032) Table 60. Global Inosine Pranobex Price by Application (2027-2032) & (USD/Unit) Table 61. North America Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 62. North America Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 64. Europe Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 68. Latin America Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Inosine Pranobex Sales by Application (2021-2026) & (US$ Million) Table 71. Newport Pharmaceuticals Company Information Table 72. Newport Pharmaceuticals Business Overview Table 73. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Newport Pharmaceuticals Inosine Pranobex Product Portfolio Table 75. Newport Pharmaceuticals Recent Development Table 76. Gedeon Richter Company Information Table 77. Gedeon Richter Business Overview Table 78. Gedeon Richter Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Gedeon Richter Inosine Pranobex Product Portfolio Table 80. Gedeon Richter Recent Development Table 81. Mochida Company Information Table 82. Mochida Business Overview Table 83. Mochida Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Mochida Inosine Pranobex Product Portfolio Table 85. Mochida Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Sanofi Inosine Pranobex Product Portfolio Table 90. Sanofi Recent Development Table 91. Andrómaco Company Information Table 92. Andrómaco Business Overview Table 93. Andrómaco Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Andrómaco Inosine Pranobex Product Portfolio Table 95. Andrómaco Recent Development Table 96. Yung Shin Company Information Table 97. Yung Shin Business Overview Table 98. Yung Shin Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Yung Shin Inosine Pranobex Product Portfolio Table 100. Yung Shin Recent Development Table 101. Alfasigma S.p.A. Company Information Table 102. Alfasigma S.p.A. Business Overview Table 103. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Alfasigma S.p.A. Inosine Pranobex Product Portfolio Table 105. Alfasigma S.p.A. Recent Development Table 106. Polfarmex Company Information Table 107. Polfarmex Business Overview Table 108. Polfarmex Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Polfarmex Inosine Pranobex Product Portfolio Table 110. Polfarmex Recent Development Table 111. Sanfer Company Information Table 112. Sanfer Business Overview Table 113. Sanfer Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Sanfer Inosine Pranobex Product Portfolio Table 115. Sanfer Recent Development Table 116. Meprofarm Company Information Table 117. Meprofarm Business Overview Table 118. Meprofarm Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Meprofarm Inosine Pranobex Product Portfolio Table 120. Meprofarm Recent Development Table 121. Novell Pharmaceutical Company Information Table 122. Novell Pharmaceutical Business Overview Table 123. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Novell Pharmaceutical Inosine Pranobex Product Portfolio Table 125. Novell Pharmaceutical Recent Development Table 126. Aflofarm Company Information Table 127. Aflofarm Business Overview Table 128. Aflofarm Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Aflofarm Inosine Pranobex Product Portfolio Table 130. Aflofarm Recent Development Table 131. North America Inosine Pranobex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 133. North America Inosine Pranobex Sales Market Share by Country (2021-2026) Table 134. North America Inosine Pranobex Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Inosine Pranobex Sales Market Share Forecast by Country (2027-2032) Table 136. North America Inosine Pranobex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Inosine Pranobex Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Inosine Pranobex Market Share by Country (2021-2026) Table 139. North America Inosine Pranobex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Inosine Pranobex Market Share Forecast by Country (2027-2032) Table 141. Europe Inosine Pranobex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 143. Europe Inosine Pranobex Sales Market Share by Country (2021-2026) Table 144. Europe Inosine Pranobex Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Inosine Pranobex Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Inosine Pranobex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Inosine Pranobex Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Inosine Pranobex Market Share by Country (2021-2026) Table 149. Europe Inosine Pranobex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Inosine Pranobex Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Inosine Pranobex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Inosine Pranobex Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Inosine Pranobex Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Inosine Pranobex Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Inosine Pranobex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Inosine Pranobex Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Inosine Pranobex Market Share by Country (2021-2026) Table 159. Asia-Pacific Inosine Pranobex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Inosine Pranobex Market Share Forecast by Country (2027-2032) Table 161. Latin America Inosine Pranobex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 163. Latin America Inosine Pranobex Sales Market Share by Country (2021-2026) Table 164. Latin America Inosine Pranobex Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Inosine Pranobex Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Inosine Pranobex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Inosine Pranobex Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Inosine Pranobex Market Share by Country (2021-2026) Table 169. Latin America Inosine Pranobex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Inosine Pranobex Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Inosine Pranobex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Inosine Pranobex Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Inosine Pranobex Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Inosine Pranobex Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Inosine Pranobex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Inosine Pranobex Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Inosine Pranobex Market Share by Country (2021-2026) Table 179. Middle East and Africa Inosine Pranobex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Inosine Pranobex Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Inosine Pranobex Distributors List Table 184. Inosine Pranobex Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Inosine Pranobex Image Figure 2. Global Inosine Pranobex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inosine Pranobex Market Size (2021-2032) & (US$ Million) Figure 4. Global Inosine Pranobex Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Syrup Image Figure 8. Global Syrup Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Inosine Pranobex Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Inosine Pranobex Market Share by Type 2025 VS 2032 Figure 11. North America Inosine Pranobex Sales Market Share in Volume by Type in 2025 Figure 12. North America Inosine Pranobex Sales Market Share in Value by Type in 2025 Figure 13. Europe Inosine Pranobex Sales Market Share in Volume by Type in 2025 Figure 14. Europe Inosine Pranobex Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Inosine Pranobex Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Inosine Pranobex Sales Market Share in Value by Type in 2025 Figure 17. Latin America Inosine Pranobex Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Inosine Pranobex Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Inosine Pranobex Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Inosine Pranobex Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Inosine Pranobex Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Immunomodulation Image Figure 24. Global Immunomodulation Sales YoY Growth (2021-2032) & (K Units) Figure 25. Antiviral Image Figure 26. Global Antiviral Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Inosine Pranobex Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Inosine Pranobex Market Share by Application 2025 VS 2032 Figure 31. North America Inosine Pranobex Sales Market Share in Volume by Application in 2025 Figure 32. North America Inosine Pranobex Sales Market Share in Value by Application in 2025 Figure 33. Europe Inosine Pranobex Sales Market Share in Volume by Application in 2025 Figure 34. Europe Inosine Pranobex Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Inosine Pranobex Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Inosine Pranobex Sales Market Share in Value by Application in 2025 Figure 37. Latin America Inosine Pranobex Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Inosine Pranobex Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Inosine Pranobex Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Inosine Pranobex Sales Market Share in Value by Application in 2025 Figure 41. North America Inosine Pranobex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Inosine Pranobex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Inosine Pranobex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Inosine Pranobex Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Inosine Pranobex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Inosine Pranobex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inosine Pranobex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Inosine Pranobex Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Inosine Pranobex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Inosine Pranobex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inosine Pranobex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Inosine Pranobex Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Inosine Pranobex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Inosine Pranobex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inosine Pranobex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Inosine Pranobex Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Inosine Pranobex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Inosine Pranobex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inosine Pranobex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Inosine Pranobex Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Inosine Pranobex Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Inosine Pranobex Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Syrup
Applications
  • Immunomodulation
  • Antiviral
  • Other
Companies covered
  • Newport Pharmaceuticals
  • Gedeon Richter
  • Mochida
  • Sanofi
  • Andrómaco
  • Yung Shin
  • Alfasigma S.p.A.
  • Polfarmex
  • Sanfer
  • Meprofarm
  • Novell Pharmaceutical
  • Aflofarm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inosine Pranobex Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inosine Pranobex Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inosine Pranobex Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Syrup
  8. 1.4 Global Inosine Pranobex Market Size by Type
  9. 1.4.1 Global Inosine Pranobex Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Inosine Pranobex Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Inosine Pranobex Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Inosine Pranobex Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Inosine Pranobex Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Inosine Pranobex Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Inosine Pranobex Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Inosine Pranobex Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inosine Pranobex Industry Trends
  2. 2.2 Inosine Pranobex Industry Drivers
  3. 2.3 Inosine Pranobex Industry Opportunities and Challenges
  4. 2.4 Inosine Pranobex Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inosine Pranobex Revenue (2021-2026)
  2. 3.2 Global Top Players by Inosine Pranobex Sales (2021-2026)
  3. 3.3 Global Top Players by Inosine Pranobex Price (2021-2026)
  4. 3.4 Global Inosine Pranobex Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inosine Pranobex Major Company Production Sites & Headquarters
  6. 3.6 Global Inosine Pranobex Company, Product Type & Application
  7. 3.7 Global Inosine Pranobex Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inosine Pranobex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inosine Pranobex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inosine Pranobex Tier 1, Tier 2, and Tier 3
4 Inosine Pranobex Regional Status and Outlook
  1. 4.1 Global Inosine Pranobex Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inosine Pranobex Historic Market Size by Region
  3. 4.2.1 Global Inosine Pranobex Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inosine Pranobex Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inosine Pranobex Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inosine Pranobex Forecasted Market Size by Region
  7. 4.3.1 Global Inosine Pranobex Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inosine Pranobex Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inosine Pranobex Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inosine Pranobex by Application
  1. 5.1 Inosine Pranobex Market by Application
  2. 5.1.1 Immunomodulation
  3. 5.1.2 Antiviral
  4. 5.1.3 Other
  5. 5.2 Global Inosine Pranobex Market Size by Application
  6. 5.2.1 Global Inosine Pranobex Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inosine Pranobex Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inosine Pranobex Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inosine Pranobex Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inosine Pranobex Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inosine Pranobex Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inosine Pranobex Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inosine Pranobex Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Newport Pharmaceuticals
  2. 6.1.1 Newport Pharmaceuticals Company Information
  3. 6.1.2 Newport Pharmaceuticals Business Overview
  4. 6.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Newport Pharmaceuticals Inosine Pranobex Product Portfolio
  6. 6.1.5 Newport Pharmaceuticals Recent Developments
  7. 6.2 Gedeon Richter
  8. 6.2.1 Gedeon Richter Company Information
  9. 6.2.2 Gedeon Richter Business Overview
  10. 6.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gedeon Richter Inosine Pranobex Product Portfolio
  12. 6.2.5 Gedeon Richter Recent Developments
  13. 6.3 Mochida
  14. 6.3.1 Mochida Company Information
  15. 6.3.2 Mochida Business Overview
  16. 6.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mochida Inosine Pranobex Product Portfolio
  18. 6.3.5 Mochida Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Inosine Pranobex Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Andrómaco
  26. 6.5.1 Andrómaco Company Information
  27. 6.5.2 Andrómaco Business Overview
  28. 6.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Andrómaco Inosine Pranobex Product Portfolio
  30. 6.5.5 Andrómaco Recent Developments
  31. 6.6 Yung Shin
  32. 6.6.1 Yung Shin Company Information
  33. 6.6.2 Yung Shin Business Overview
  34. 6.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Yung Shin Inosine Pranobex Product Portfolio
  36. 6.6.5 Yung Shin Recent Developments
  37. 6.7 Alfasigma S.p.A.
  38. 6.7.1 Alfasigma S.p.A. Company Information
  39. 6.7.2 Alfasigma S.p.A. Business Overview
  40. 6.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Alfasigma S.p.A. Inosine Pranobex Product Portfolio
  42. 6.7.5 Alfasigma S.p.A. Recent Developments
  43. 6.8 Polfarmex
  44. 6.8.1 Polfarmex Company Information
  45. 6.8.2 Polfarmex Business Overview
  46. 6.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Polfarmex Inosine Pranobex Product Portfolio
  48. 6.8.5 Polfarmex Recent Developments
  49. 6.9 Sanfer
  50. 6.9.1 Sanfer Company Information
  51. 6.9.2 Sanfer Business Overview
  52. 6.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanfer Inosine Pranobex Product Portfolio
  54. 6.9.5 Sanfer Recent Developments
  55. 6.10 Meprofarm
  56. 6.10.1 Meprofarm Company Information
  57. 6.10.2 Meprofarm Business Overview
  58. 6.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Meprofarm Inosine Pranobex Product Portfolio
  60. 6.10.5 Meprofarm Recent Developments
  61. 6.11 Novell Pharmaceutical
  62. 6.11.1 Novell Pharmaceutical Company Information
  63. 6.11.2 Novell Pharmaceutical Business Overview
  64. 6.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novell Pharmaceutical Inosine Pranobex Product Portfolio
  66. 6.11.5 Novell Pharmaceutical Recent Developments
  67. 6.12 Aflofarm
  68. 6.12.1 Aflofarm Company Information
  69. 6.12.2 Aflofarm Business Overview
  70. 6.12.3 Aflofarm Inosine Pranobex Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aflofarm Inosine Pranobex Product Portfolio
  72. 6.12.5 Aflofarm Recent Developments
7 North America by Country
  1. 7.1 North America Inosine Pranobex Sales by Country
  2. 7.1.1 North America Inosine Pranobex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inosine Pranobex Sales by Country (2021-2026)
  4. 7.1.3 North America Inosine Pranobex Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inosine Pranobex Market Size by Country
  6. 7.2.1 North America Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inosine Pranobex Market Size by Country (2021-2026)
  8. 7.2.3 North America Inosine Pranobex Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inosine Pranobex Sales by Country
  2. 8.1.1 Europe Inosine Pranobex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inosine Pranobex Sales by Country (2021-2026)
  4. 8.1.3 Europe Inosine Pranobex Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inosine Pranobex Market Size by Country
  6. 8.2.1 Europe Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inosine Pranobex Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inosine Pranobex Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inosine Pranobex Sales by Country
  2. 9.1.1 Asia-Pacific Inosine Pranobex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inosine Pranobex Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inosine Pranobex Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inosine Pranobex Market Size by Country
  6. 9.2.1 Asia-Pacific Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inosine Pranobex Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inosine Pranobex Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inosine Pranobex Sales by Country
  2. 10.1.1 South America Inosine Pranobex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inosine Pranobex Sales by Country (2021-2026)
  4. 10.1.3 South America Inosine Pranobex Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inosine Pranobex Market Size by Country
  6. 10.2.1 South America Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inosine Pranobex Market Size by Country (2021-2026)
  8. 10.2.3 South America Inosine Pranobex Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inosine Pranobex Sales by Country
  2. 11.1.1 Middle East and Africa Inosine Pranobex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inosine Pranobex Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inosine Pranobex Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inosine Pranobex Market Size by Country
  6. 11.2.1 Middle East and Africa Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inosine Pranobex Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inosine Pranobex Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inosine Pranobex Value Chain Analysis
  2. 12.1.1 Inosine Pranobex Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inosine Pranobex Production Mode & Process
  7. 12.2 Inosine Pranobex Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inosine Pranobex Distributors
  10. 12.2.3 Inosine Pranobex Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst